Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis.

Yin M, Dai J, Sun R, Wang Y

Open source

DOI
10.1080/07853890.2025.2583319
Published
2025 Dec
Container
Annals of medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/07853890.2025.2583319,
  title = {Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis.},
  author = {Yin M and Dai J and Sun R and Wang Y},
  year = {2025},
  journal = {Annals of medicine},
  doi = {10.1080/07853890.2025.2583319},
  url = {https://doi.org/10.1080/07853890.2025.2583319}
}

RIS

TY  - JOUR
TI  - Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis.
AU  - Yin M
AU  - Dai J
AU  - Sun R
AU  - Wang Y
PY  - 2025
JO  - Annals of medicine
DO  - 10.1080/07853890.2025.2583319
UR  - https://doi.org/10.1080/07853890.2025.2583319
ER  - 

APA

M, Y., J, D., R, S., & Y, W. (2025). Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis.. Annals of medicine. https://doi.org/10.1080/07853890.2025.2583319

Source records